- Home
- RLAY vs VINP Comparison
RLAY vs VINP Comparison
Compare RLAY & VINP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- VINP
- Stock Information
- Founded
- RLAY 2015
- VINP 2009
- Country
- RLAY United States
- VINP Brazil
- Employees
- RLAY N/A
- VINP N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- VINP Investment Managers
- Sector
- RLAY Health Care
- VINP Finance
- Exchange
- RLAY Nasdaq
- VINP Nasdaq
- Market Cap
- RLAY 619.0M
- VINP 636.2M
- IPO Year
- RLAY 2020
- VINP 2021
- Fundamental
- Price
- RLAY $4.12
- VINP $10.15
- Analyst Decision
- RLAY Strong Buy
- VINP Strong Buy
- Analyst Count
- RLAY 13
- VINP 2
- Target Price
- RLAY $18.00
- VINP $13.50
- AVG Volume (30 Days)
- RLAY 1.5M
- VINP 41.0K
- Earning Date
- RLAY 11-05-2025
- VINP 11-06-2025
- Dividend Yield
- RLAY N/A
- VINP 6.40%
- EPS Growth
- RLAY N/A
- VINP N/A
- EPS
- RLAY N/A
- VINP 0.50
- Revenue
- RLAY $8,355,000.00
- VINP $153,475,995.00
- Revenue This Year
- RLAY $31.55
- VINP $67.62
- Revenue Next Year
- RLAY N/A
- VINP $14.50
- P/E Ratio
- RLAY N/A
- VINP $20.20
- Revenue Growth
- RLAY N/A
- VINP 76.11
- 52 Week Low
- RLAY $1.78
- VINP $8.66
- 52 Week High
- RLAY $10.72
- VINP $10.99
- Technical
- Relative Strength Index (RSI)
- RLAY 65.83
- VINP 57.49
- Support Level
- RLAY $3.52
- VINP $9.82
- Resistance Level
- RLAY $4.26
- VINP $10.18
- Average True Range (ATR)
- RLAY 0.22
- VINP 0.27
- MACD
- RLAY 0.07
- VINP 0.00
- Stochastic Oscillator
- RLAY 85.26
- VINP 75.81
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About VINP Vinci Partners Investments Ltd.
Vinci Compass Investments Ltd is an alternative investment platform in Brazil. Its business segments include Private Equity, Equities, Real Assets, Credit, Global IP&S, and Corporate Advisory. The company's majority of its revenue comes from the Private Equity segment, which is comprised of five business lines: private equity, real estate, infrastructure, credit, and special situations.